tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Shanghai Junshi Biosciences Enhances Corporate Governance with New Audit Committee Terms

Story Highlights
Shanghai Junshi Biosciences Enhances Corporate Governance with New Audit Committee Terms

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

The latest announcement is out from Shanghai Junshi Biosciences Co., Ltd. Class H ( (HK:1877) ).

Shanghai Junshi Biosciences Co., Ltd. has released the terms of reference for its Audit Committee of the Board of Directors. This document outlines the general provisions, composition, duties and powers, chairman’s responsibilities, working procedure, rules of procedure, and supplementary provisions for the committee. The release of these terms is a significant step in enhancing the company’s corporate governance and ensuring transparency and accountability in its financial reporting processes.

The most recent analyst rating on (HK:1877) stock is a Hold with a HK$29.00 price target. To see the full list of analyst forecasts on Shanghai Junshi Biosciences Co., Ltd. Class H stock, see the HK:1877 Stock Forecast page.

More about Shanghai Junshi Biosciences Co., Ltd. Class H

Average Trading Volume: 13,773,473

Technical Sentiment Signal: Buy

Current Market Cap: HK$48.06B

For a thorough assessment of 1877 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1